미국 · 보도자료 · Spectral AI, Inc. · 2026-10-01 12:30
딥뷰 시스템, 두경부·손발 화상 적응증 확대 임상 개시
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit (“SIV”) associated with the commencement of a clinical study designed to support a label
